Zepbound Cost Calculator 2026
Zepbound KwikPens from $299/month through LillyDirect. FDA-approved for weight loss. Find out what you'll actually pay.
List price $1,059/month. Same tirzepatide as Mounjaro — but different insurance coverage.
Estimate Your Monthly Cost
⚠️ Indicated for obesity/weight loss — Eli Lilly
2026 GLP-1 Drug Pricing Comparison
| Drug | List Price | With Insurance | Savings Card | For |
|---|---|---|---|---|
Wegovy semaglutide | $1,640 | ~$25–50 | $25/mo | obesity |
Ozempic semaglutide | $1,029 | ~$25–50 | $25/mo | type 2 diabetes |
Mounjaro tirzepatide | $1,069 | ~$25–50 | $25/mo | type 2 diabetes |
Zepbound tirzepatide | $1,059 | ~$25–50 | $25/mo | obesity |
Saxenda liraglutide | $1,349 | ~$100–50 | $100/mo | obesity |
Rybelsus semaglutide (oral) | $998 | ~$10–50 | $10/mo | type 2 diabetes |
Wegovy Pills (oral semaglutide) semaglutide (oral) | $299 | ~$25–50 | $25/mo | obesity |
Prices as of 2026. Actual copays depend on your specific plan. Savings card eligibility varies.
How Much Does Zepbound Cost in 2026?
Zepbound (tirzepatide) carries a list price of $1,059/month in 2026. Like all GLP-1 and dual agonist medications, almost nobody pays this amount. Through Eli Lilly's LillyDirect KwikPen program, self-pay patients access Zepbound at $299–$449/month depending on dose. With commercial insurance that covers AOM medications, the cost drops to $25/month with the Lilly savings card.
Zepbound is FDA-approved for chronic weight management in adults with a BMI of 30 or higher (or 27+ with a weight-related condition). It's the weight-loss brand of tirzepatide — while Mounjaro is the same molecule marketed for Type 2 diabetes. This distinction has major implications for insurance coverage and Medicare access.
Zepbound KwikPens — The Self-Pay Breakthrough
Eli Lilly's LillyDirect KwikPen program is one of the clearest self-pay options for any GLP-1 medication. Patients with a valid prescription can order Zepbound KwikPens directly at:
- 2.5mg and 5mg (starter/titration doses): $299/month
- 7.5mg and 10mg (mid-range doses): ~$349/month
- 12.5mg and 15mg (maintenance doses): ~$449/month
No insurance is required. No income verification. The KwikPens are single-use auto-injectors — the same formulation as standard Zepbound. They ship directly to your home through participating pharmacies connected to LillyDirect. This is the most transparent and predictable cash-pay pricing available for tirzepatide.
Insurance Coverage for Zepbound in 2026
Commercial Insurance
Coverage depends on whether your employer's health plan includes anti-obesity medication (AOM) benefits. Approximately 40% of employer health plans covered some AOM medications as of 2025, up from 25% in 2021. If your plan covers AOMs, expect to pay $25–$100/month for Zepbound with prior authorization. The Lilly savings card brings this down to $25/month for eligible commercially insured patients.
Prior authorization for Zepbound requires: BMI ≥30 (or ≥27 with a weight-related comorbidity), documentation of previous weight loss attempts (lifestyle intervention), and often a step therapy requirement (trying a lower-cost AOM first). Your doctor handles the PA process — it typically takes 2–4 weeks.
Medicare and Zepbound
Medicare does not cover Zepbound for weight loss in 2026. This is one of the largest coverage gaps in American healthcare, affecting millions of older adults who could benefit from the medication. Congressional action (the Treat and Reduce Obesity Act) would change this, but it has not been signed into law as of April 2026.
If you have both obesity and Type 2 diabetes and are on Medicare, ask your doctor whether Mounjaro (same active ingredient) could be prescribed for T2D management. Mounjaro IS covered by Medicare Part D and costs $0–$50/month for most Part D enrollees — for the same tirzepatide molecule at the same doses.
Zepbound vs. Wegovy — Which Is Cheaper?
Both are FDA-approved for weight management but cost differently depending on how you pay:
| Scenario | Zepbound | Wegovy Injectable | Wegovy Pill |
|---|---|---|---|
| List price | $1,059/mo | $1,640/mo | $299/mo |
| Direct program | $299/mo (LillyDirect) | $349/mo (NovoCare) | $149/mo (NovoCare) |
| Savings card | $25/mo | $25/mo | $25/mo |
| Medicare | Not covered | Not covered | Not covered |
For self-pay patients: Wegovy Pill at $149/month beats everything. For injections: Zepbound via LillyDirect ($299/mo) is cheaper than Wegovy via NovoCare ($349/mo). For insured patients: both are equivalent at $25/month with savings cards.
Frequently Asked Questions
How much does Zepbound cost per month in 2026?
Zepbound's list price is $1,059/month in 2026. Through LillyDirect KwikPen program, self-pay patients pay $299–$449/month depending on dose. With commercial insurance that covers AOM medications, plus the Lilly savings card, out-of-pocket cost is typically $25/month. Medicare does not cover Zepbound for weight loss. Without insurance, LillyDirect at $299/month is the most reliable low-cost option.
What are Zepbound KwikPens and how do they affect cost?
Zepbound KwikPens are single-use auto-injectors that Eli Lilly sells directly to patients through LillyDirect at $299–$449/month — a significant discount from the $1,059 list price. The KwikPens contain the same tirzepatide as standard Zepbound vials. They require a prescription but no insurance. This self-pay program was designed to make Zepbound accessible to patients without AOM insurance coverage.
Does insurance cover Zepbound?
Commercial insurance coverage for Zepbound depends on whether your employer plan includes anti-obesity medication (AOM) benefits. Plans with AOM coverage typically cover Zepbound at $25–$100/month copay with prior authorization. Plans without AOM benefits do not cover Zepbound. Medicare does not cover Zepbound for weight loss. Most state Medicaid programs exclude Zepbound for obesity.
How does Zepbound compare to Wegovy on cost?
Zepbound and Wegovy are both FDA-approved for weight management but use different active ingredients. At list price, Zepbound ($1,059/mo) is slightly cheaper than Wegovy injectable ($1,640/mo). Both have similar savings card pricing ($25/mo with commercial insurance). Cash-pay through LillyDirect ($299/mo) is cheaper than Wegovy injectable through NovoCare ($349/mo). However, Wegovy now offers an oral pill at $149/mo through NovoCare — making it the cheapest branded self-pay option.
Is Zepbound covered by Medicare?
No. Medicare does not cover Zepbound for weight loss as of 2026. The Treat and Reduce Obesity Act (TROA) would change this, but it has not been signed into law. Some Medicare Advantage plans offer supplemental AOM coverage — check your plan's Evidence of Coverage. If you have Type 2 diabetes, Mounjaro (same active ingredient as Zepbound) IS covered by Medicare Part D.
Compare other GLP-1 medications: